Cold Remedies Market by Drug Type (Antihistamines, Expectorants, Bronchodilators, Decongestants, and Antibiotics), Dosage Type (Oral Syrups, Tablets/Pills, Nasal Drops, and Lozenges), and Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Supermarkets/Hypermarkets, and e-Commerce/Online Pharmacies) - Global Opportunity Analysis and Industry Forecast, 2018-2025

Get 20% Free Customization In This Report

Pharmaceuticals	LI_183585	Pages: NA	May 2019 \| 1007 Views
Author(s) : NA	Tables: NA	Charts: NA	Formats*:

Cold is an infectious disease that affects the respiratory system. The common symptoms for cold include sneezing, sore throat, a stuffy nose, and coughing. Cold remedies are used to treat cold in immunosuppressed individuals. The composition of many cold medicines are same and therefore taking too much of certain medication can lead to drug resistance or serious injury.

Rise in geriatric population, demand for effective combination products, and switch from Rx to OTC category drive the market. However, competition faced by international players due to drugs from local manufacturers and natural remedies restrain the market growth. Favorable regulations and opportunities in the emerging economies of Asia-Pacific and LAMEA due to availability of large patient pools provide growth prospects for the market.

The report segments the global cold remedies market based on drug type, dosage type, end user, and region. Based on drug type, it is divided into antihistamines, expectorants, bronchodilators, decongestants, antibiotics, and others. Based on dosage type, it is classified into oral syrups, tablets/pills, nasal drops, lozenges, and others.

By distribution channel, it is categorized into hospital pharmacies, retail pharmacies, drug stores, supermarkets/hypermarkets, and e-commerce/online pharmacies. By geography, it is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).

Key players operating in the market include Reckitt Benckiser Group plc, Johnson & Johnson, GlaxoSmithKline plc, Novartis AG, Bayer AG, AstraZeneca plc, Sun Pharmaceutical Industries Ltd., Pfizer Inc., Prestige Brands Holdings, Inc., and Procter & Gamble Co.

Key Benefits

The study provides an in-depth analysis of the global market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
Competitive intelligence highlights the business practices followed by leading players across various regions.
Comprehensive analysis of all geographic regions are provided that helps determine the prevailing opportunities in these regions.
Key market players within the market are profiled in the report and their strategies are analyzed thoroughly, which elucidates the competitive outlook of the global market.
Extensive analysis of the market is conducted by closely following key product positioning and monitoring the top contenders within the market framework.

Cold Remedies Market Key Segments:

By Drug Type

Antihistamines
Expectorants
Bronchodilators
Decongestants
Antibiotics
Others

By Dosage Type

Oral Syrups
Tablets/Pills
Nasal Drops
Lozenges
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Drug Stores
Supermarkets/Hypermarkets
e-Commerce/Online Pharmacies

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.5. MARKET DYNAMICS

3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities

Chapter: 4 COLD REMEDIES MARKET, BY DRUG TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ANTIHISTAMINES

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. EXPECTORANTS

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. BRONCHODILATORS

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. DECONGESTANTS

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

4.6. ANTIBIOTICS

4.6.1. Key market trends
4.6.2. Growth factors and opportunities
4.6.3. Market size and forecast

4.7. OTHERS

4.7.1. Key market trends
4.7.2. Growth factors and opportunities
4.7.3. Market size and forecast

Chapter: 5 COLD REMEDIES MARKET, BY DOSAGE TYPE

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. ORAL SYRUPS

5.2.1. Market size and forecast

5.3. TABLETS/PILLS

5.3.1. Market size and forecast

5.4. NASAL DROPS

5.4.1. Market size and forecast

5.5. LOZENGES

5.5.1. Market size and forecast

5.6. OTHERS

5.6.1. Market size and forecast

Chapter: 6 COLD REMEDIES MARKET, BY DISTRIBUTION CHANNEL

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. HOSPITAL PHARMACIES

6.2.1. Market size and forecast

6.3. RETAIL PHARMACIES

6.3.1. Market size and forecast

6.4. DRUG STORES

6.4.1. Market size and forecast

6.5. SUPERMARKETS/HYPERMARKETS

6.5.1. Market size and forecast

6.6. E-COMMERCE/ONLINE PHARMACIES

6.6.1. Market size and forecast

Chapter: 7 COLD REMEDIES MARKET, BY REGION

7.1. OVERVIEW
7.2. NORTH AMERICA

7.2.1. Key market trends
7.2.2. Key growth factors and opportunities
7.2.3. Market size and forecast

7.2.3.1. U.S. market size and forecast
7.2.3.2. Canada market size and forecast
7.2.3.3. Mexico market size and forecast

7.2.4. North America Cold Remedies Market by Drug Type
7.2.5. North America Cold Remedies Market by Dosage Type
7.2.6. North America Cold Remedies Market by Distribution Channel

7.3. EUROPE

7.3.1. Key market trends
7.3.2. Key growth factors and opportunities
7.3.3. Market size and forecast

7.3.3.1. Germany market size and forecast
7.3.3.2. France market size and forecast
7.3.3.3. UK market size and forecast
7.3.3.4. Italy market size and forecast
7.3.3.5. Spain market size and forecast
7.3.3.6. Rest of Europe market size and forecast

7.3.4. Europe Cold Remedies Market by Drug Type
7.3.5. Europe Cold Remedies Market by Dosage Type
7.3.6. Europe Cold Remedies Market by Distribution Channel

7.4. ASIA-PACIFIC

7.4.1. Key market trends
7.4.2. Key growth factors and opportunities
7.4.3. Market size and forecast

7.4.3.1. Japan market size and forecast
7.4.3.2. China market size and forecast
7.4.3.3. Australia market size and forecast
7.4.3.4. India market size and forecast
7.4.3.5. South Korea market size and forecast
7.4.3.6. Rest of Asia-Pacific market size and forecast

7.4.4. Asia-Pacific Cold Remedies Market by Drug Type
7.4.5. Asia-Pacific Cold Remedies Market by Dosage Type
7.4.6. Asia-Pacific Cold Remedies Market by Distribution Channel

7.5. LAMEA

7.5.1. Key market trends
7.5.2. Key growth factors and opportunities
7.5.3. Market size and forecast

7.5.3.1. Brazil market size and forecast
7.5.3.2. Saudi Arabia market size and forecast
7.5.3.3. South Africa market size and forecast
7.5.3.4. Rest of LAMEA market size and forecast

7.5.4. LAMEA Cold Remedies Market by Drug Type
7.5.5. LAMEA Cold Remedies Market by Dosage Type
7.5.6. LAMEA Cold Remedies Market by Distribution Channel

Chapter: 8 COMPANY PROFILES

8.1. RECKITT BENCKISER GROUP PLC

8.1.1. Operating business segments
8.1.2. Business performance
8.1.3. Key strategic moves and developments

8.2. JOHNSON & JOHNSON

8.2.1. Operating business segments
8.2.2. Business performance
8.2.3. Key strategic moves and developments

8.3. GLAXOSMITHKLINE PLC.

8.3.1. Operating business segments
8.3.2. Business performance
8.3.3. Key strategic moves and developments

8.4. NOVARTIS AG

8.4.1. Operating business segments
8.4.2. Business performance
8.4.3. Key strategic moves and developments

8.5. BAYER AG

8.5.1. Operating business segments
8.5.2. Business performance
8.5.3. Key strategic moves and developments

8.6. ASTRAZENECA PLC

8.6.1. Operating business segments
8.6.2. Business performance
8.6.3. Key strategic moves and developments

8.7. SUN PHARMACEUTICAL INDUSTRIES LTD.

8.7.1. Operating business segments
8.7.2. Business performance
8.7.3. Key strategic moves and developments

8.8. PFIZER INC.

8.8.1. Operating business segments
8.8.2. Business performance
8.8.3. Key strategic moves and developments

8.9. PRESTIGE BRANDS HOLDINGS, INC.

8.9.1. Operating business segments
8.9.2. Business performance
8.9.3. Key strategic moves and developments

8.10. PROCTER & GAMBLE CO.

8.10.1. Operating business segments
8.10.2. Business performance
8.10.3. Key strategic moves and developments

"Note : The list of companies mentioned in the description is tentative in nature and may change after detailed analysis."

With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
Technologically sophisticated and reliable insights through well audited and veracious research methodology
Sovereign research proceeds that present a tangible depiction of marketplace

With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

Patent and regulatory databases for understanding of technical & legal developments
Scientific and technical writings for product information and related preemptions
Regional government and statistical databases for macro analysis
Authentic new articles, web-casts and other related releases for market evaluation
Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast

Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

Validates and improves the data quality and strengthens research proceeds
Further develops analyst team’s market understanding and expertise
Supplies authentic information about market size, share, growth and forecasts

Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

Chief executives and VPs of leading corporations specific to industry
Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)

Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.

Shopping Cart is Empty..

Your Shopping Cart Is Empty

Cold Remedies Market Key Segments:

By Drug Type

By Dosage Type

By Distribution Channel

By Region

PURCHASE OPTIONS

Reach out to us

Request TOC/Sample

Request Customization

Request TOC/Sample

Why Allied Market Research

Infallible Methodology

Analyst Support

Customization

TARGETED MARKET VIEW

Featured Reports

Featured Readings

Get Fresh content delivered

About

Contact Us

Find Help

Get notification about our new releases

Our Products & Services

CONNECT WITH US

Press Media

We Accept